@ Newsroom | SEBIO

Florida Institute Funds Alachua-based Amend Surgical

Posted by on May 23, 2017 in Newsroom | 0 comments

GAINESVILLE and BOCA RATON, FL. – The Florida Institute for the Commercialization of Public Research (the Florida Institute) announced today that it has finalized a funding agreement with Amend Surgical, an Alachua-based medical device company with newly licensed technology developed at the University of Florida. The Florida Institute supports new company development and expansion based on publicly-funded research, and bridges early funding gaps for companies licensing technology out of Florida-based universities and research institutions. Amend Surgical is a specialty medical...

Read More

Local venture capital firm has $31M to invest in ag-tech startups

Posted by on May 17, 2017 in Newsroom | 0 comments

MEMPHIS, TN. – A Memphis-based venture capital fund announced the close of a $31 million fund focused on rural America. Innova announced the close of Innova Ag Innovation Fund IV, which will focus on early stage investments in rural America and work with national farm organizations and other partners to identify, enable and accelerate ag-tech companies with high growth potential. As part of the U.S. Department of Agriculture’s (USDA’s) Rural Business Investment Program, the fund has been certified and licensed to operate as a Rural Business Investment Company (RBIC). This...

Read More

Cantex Pharmaceuticals, Inc. Announces Initiation of Phase 2 Clinical Development for CX-02 in Recur

Posted by on May 2, 2017 in Newsroom | 0 comments

WESTON, FL. –  Cantex Pharmaceuticals Inc., a clinical stage biopharmaceutical company developing proprietary pharmaceuticals that improve the treatment of cancers and other life-threatening disorders, today announced that dosing has been initiated in its Phase 2 clinical trial for CX-02, Cantex’s proprietary combination of disulfiram + copper (DSF-Cu), in recurrent glioblastoma. The trial’s principal investigator is Jiayi Huang, M.D., at Washington University School of Medicine in St. Louis. “Evidence found in pre-clinical studies has strongly indicated that...

Read More

What the Milken Institute Rankings Mean to Me (or Why We Do What We Do)

Posted by on Apr 28, 2017 in Newsroom | 0 comments

GAINESVILLE, FL. – The March for Science made front page news all over the United States as we celebrated Earth Day, but the profession of tech transfer marches in support of science every day — whether the media is watching or not. At the University of Florida Office of Technology Licensing, we like to think we make a difference for the #GatorGood, indeed, the greater global good, every time we help move a scientist’s discovery from the lab into the marketplace where it can make the world a better place. Last week, the Milken Institute released its newest ranking of the...

Read More

Alabama team seeks new life sciences markets in Europe

Posted by on Apr 26, 2017 in Newsroom | 0 comments

BIRMINGHAM, AL. – Alabama business and community leaders are in Europe the week of April 24, 2017, seeking new market opportunities for the state’s growing bioscience industry in Germany and Denmark. The 22-member delegation also is promoting the cutting-edge developments happening at research centers from Huntsville to Birmingham to Mobile and beyond, an effort to encourage new investment in the state as a gateway to the broader U.S. life sciences sector. Alabama Secretary of Commerce Greg Canfield is leading the trade mission, which kicked off Monday in Berlin with meetings at the...

Read More

Captozyme Opens Up New Headquarters

Posted by on Apr 22, 2017 in Newsroom | 0 comments

GAINSVILLE, FL. – Upon graduating from the University of Florida’s Innovation Hub, local biotechnology company, Captozyme Inc., recently acquired a newly constructed facility to house their new headquarters at 1622 NW 55th Place. The company plans to consolidate all operations there during the coming months, and is proud to be part of the developing biotechnology scene of Gainesville. “Settling down in Gainesville is a natural next step in our vision,” said Helena Cowley, Captozyme CEO. “We owe so much of our success to the local community; entrepreneurs, mentors, and...

Read More